3SBio Inc. (HKG:1530)
25.50
-0.30 (-1.16%)
Dec 18, 2025, 1:25 PM HKT
3SBio Market Cap
3SBio has a market cap or net worth of 64.44 billion as of December 17, 2025. Its market cap has increased by 387.70% in one year.
Market Cap
64.44B
Enterprise Value
62.29B
Revenue
9.94B
Ranking
n/a
PE Ratio
24.55
Stock Price
25.50
Market Cap Chart
Since June 11, 2015, 3SBio's market cap has increased from 22.67B to 64.44B, an increase of 184.27%. That is a compound annual growth rate of 10.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 64.44B | 350.00% |
| Dec 31, 2024 | 14.32B | -20.61% |
| Dec 29, 2023 | 18.04B | -10.89% |
| Dec 30, 2022 | 20.24B | 23.46% |
| Dec 31, 2021 | 16.40B | -8.83% |
| Dec 31, 2020 | 17.98B | -29.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 261.96B |
| Hansoh Pharmaceutical Group Company | 236.95B |
| JD Health International | 179.92B |
| Innovent Biologics | 138.73B |
| WuXi Biologics | 132.35B |
| Sino Biopharmaceutical | 115.48B |
| Akeso | 107.68B |
| Sichuan Kelun-Biotech Biopharmaceutical | 94.81B |